BJDX
Price
$2.79Alerts
Change
-$0.02 (-0.71%)
Updated
Nov 11 closing price
Capitalization
2.43M
2 days until earnings call
Intraday BUY SELL Signals
RDNT
Price
$78.08Alerts
Change
+$0.14 (+0.18%)
Updated
Nov 11 closing price
Capitalization
5.98B
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BJDX vs RDNT

BJDX vs RDNT Comparison Chart in %
View a ticker or compare two or three
VS
BJDX vs. RDNT commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BJDX is a Buy and RDNT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BJDX with price predictions
Nov 10, 2026

Momentum Indicator for BJDX turns positive, indicating new upward trend

BJDX saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned positive. In 87 of the 102 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BJDX's RSI Indicator exited the oversold zone, 35 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 65 of 77 cases where BJDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for BJDX just turned positive on November 05, 2026. Looking at past instances where BJDX's MACD turned positive, the stock continued to rise in 32 of 39 cases over the following month. The odds of a continued upward trend are 82%.

Following a +19.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where BJDX advanced for three days, in 145 of 182 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BJDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

BJDX broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BJDX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.258) is normal, around the industry mean (4.142). P/E Ratio (-1.035) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. BJDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BJDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for RDNT with price predictions
Nov 10, 2026

RDNT in upward trend: 10-day moving average crossed above 50-day moving average on November 04, 2026

The 10-day moving average for RDNT crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on RDNT as a result. In 64 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for RDNT just turned positive on October 22, 2026. Looking at past instances where RDNT's MACD turned positive, the stock continued to rise in 45 of 54 cases over the following month. The odds of a continued upward trend are 83%.

RDNT moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +9.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in 230 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

The Aroon Indicator entered an Uptrend today. In 181 of 210 cases where RDNT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.

Bearish Trend Analysis

The 10-day RSI Indicator for RDNT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 26 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 59 cases where RDNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

RDNT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.457) is normal, around the industry mean (67.298). RDNT's P/E Ratio (-292.308) is considerably lower than the industry average of (4.239). Projected Growth (PEG Ratio) (0.260) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.567) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. RDNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
RDNT: Fundamental Ratings
RDNT
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
36
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BJDXRDNT
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BJDX: $2.81 vs. RDNT: $77.94)
Brand notoriety: BJDX and RDNT are both not notable
BJDX represents the Medical/Nursing Services, while RDNT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BJDX: 26% vs. RDNT: 75%
Market capitalization -- BJDX: $2.43M vs. RDNT: $5.98B
BJDX [@Medical/Nursing Services] is valued at $2.43M. RDNT’s [@Medical Specialties] market capitalization is $5.98B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BJDX’s FA Score shows that 0 FA rating(s) are green while RDNT’s FA Score has 1 green FA rating(s).

  • BJDX’s FA Score: 0 green, 5 red.
  • RDNT’s FA Score: 1 green, 4 red.
According to our system of comparison, RDNT is a better buy in the long-term than BJDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BJDX’s TA Score shows that 5 TA indicator(s) are bullish while RDNT’s TA Score has 6 bullish TA indicator(s).

  • BJDX’s TA Score: 5 bullish, 3 bearish.
  • RDNT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BJDX and RDNT are a good buy in the short-term.

Price Growth

BJDX (@Medical/Nursing Services) experienced а +27.15% price change this week, while RDNT (@Medical Specialties) price change was +6.50% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.92%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +38.31%.

Reported Earning Dates

BJDX is expected to report earnings on Nov 13, 2026.

RDNT is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-4.92% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
Interact to see
Advertisement

BJDX and

Correlation & Price change

A.I.dvisor tells us that BJDX and CVRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BJDX and CVRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BJDX
1D Price
Change %
BJDX100%
+13.77%
CVRX - BJDX
30%
Poorly correlated
-10.93%
MBOT - BJDX
23%
Poorly correlated
-4.55%
PSNL - BJDX
23%
Poorly correlated
-0.44%
RDNT - BJDX
22%
Poorly correlated
-0.56%
CTSO - BJDX
22%
Poorly correlated
-0.51%
More

RDNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDNT
1D Price
Change %
RDNT100%
-0.56%
ITGR - RDNT
49%
Loosely correlated
+0.05%
GKOS - RDNT
48%
Loosely correlated
-1.07%
NNOX - RDNT
46%
Loosely correlated
+59.80%
ICUI - RDNT
43%
Loosely correlated
+1.82%
CERS - RDNT
42%
Loosely correlated
-5.80%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VOX182.120.27
+0.15%
Vanguard Communication Services ETF (VOX)
SIMS45.70N/A
N/A
State Street SPDR S&P Kensho Intelligent Structures ETF (SIMS)
UFEB39.49-0.04
-0.10%
Innovator U.S. Equity Ultra Buffer ETF - February (UFEB)
STPZ51.75-0.19
-0.37%
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund (STPZ)
TEKY39.16-0.25
-0.62%
Lazard Next Gen Technologies ETF (TEKY)